Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / VBLT - VBL Therapeutics: A Speculative Play With An Enticing Risk-Reward Profile

VBLT - VBL Therapeutics: A Speculative Play With An Enticing Risk-Reward Profile

Vascular Biogenics Ltd.
  • While doing some speculative biotech window shopping, I came across VBL Therapeutics sitting on the sub-$100M market cap shelf. After a quick inspection, I am heading to the checkout.
  • The company's lead candidate, VB-111, is moving closer to the finish line in platinum-resistant ovarian cancer. So far, VB-111 has shown to have at least a 58% response rate.
  • I believe the VBLT's risk-reward profile favors a long position due to its potential upside and its current valuation.
  • I discuss my leading downside risks and will reveal how I plan to initiate a position in VBLT.

For further details see:

VBL Therapeutics: A Speculative Play With An Enticing Risk-Reward Profile
Stock Information
Company Name: Vascular Biogenics Ltd.
Stock Symbol: VBLT
Market: NASDAQ
Menu
VBLT VBLT Quote VBLT Short VBLT News VBLT Articles VBLT Message Board
Get VBLT Alerts

News, Short Squeeze, Breakout and More Instantly...